©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 812-826
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.812
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.812
Table 2 The relation between von-Willebrand factor and stage of disease, systemic inflammatory response syndrome, and other inflammatory and prognostic indicators1
| Parameter | vWF | P value | ||||||
| n | mean ± SD | Min | Max | Percentiles | ||||
| 25th | 50th | 75th | ||||||
| CTP score | ||||||||
| Class A | 18 | 258.0 ± 104.2 | 150 | 586 | 190.0 | 228.0 | 276.0 | Kruskal-Wallis H test: Chi-square (2) = 10.8177; P = 0.0045a |
| Class B | 25 | 336.5 ± 122.5 | 150 | 650 | 262.0 | 341.0 | 400.0 | |
| Class C | 28 | 411.5 ± 182.2 | 198 | 850 | 246.0 | 402.8 | 560.0 | |
| Class А/B = Mann-Whitney U test: Z = -2.191; P = 0.028a | ||||||||
| Class А/C = Mann-Whitney U test: Z = -3.028; P = 0.002a | ||||||||
| Class B/C = Mann-Whitney U test: Z = -1.639; P = 0.101 | ||||||||
| MELD score | ||||||||
| Group 1 | 9 | 271.5 ± 106.3 | 150 | 513 | 225.0 | 257.0 | 276.0 | Kruskal-Wallis H test: Chi-square (2) = 10.3357; P = 0.0057a |
| Group 2 | 33 | 301.0 ± 115.9 | 161 | 650 | 200.0 | 296.0 | 350.0 | |
| Group 3 | 29 | 420.8 ± 179.7 | 150 | 850 | 258.0 | 409.0 | 548.0 | |
| Group 1/2 = Mann-Whitney U test: Z = -0.690; P = 0.507 | ||||||||
| Group 1/3 = Mann-Whitney U test: Z = -0.031; P = 0.029a | ||||||||
| Group 2/3 = Mann-Whitney U test: Z = -2.942; P = 0.003a | ||||||||
| SIRS score | ||||||||
| SIRS (+) | 43 | 339.2 ± 142.0 | 150 | 680 | 200.0 | 336.5 | 409.0 | Mann-Whitney U test: Z = -0.3529; P = 0.7241 |
| SIRS (-) | 28 | 356.9 ± 177.5 | 150 | 850 | 216.0 | 309.2 | 410.8 | |
| Ferritin (ng/mL) | ||||||||
| < 200 | 39 | 310.0 ± 140.7 | 150.0 | 650.0 | 198.0 | 262.0 | 405.0 | Kruskal-Wallis H test: Chi-square (2) = 7.1653; P = 0.0278a |
| 200-400 | 5 | 343.3 ± 91.2 | 253.0 | 458.9 | 258.0 | 336.5 | 410.1 | |
| > 400 | 18 | 423.9 ± 171.0 | 199.7 | 850.0 | 300.0 | 400.5 | 548.0 | |
| < 200/200-400 = Mann-Whitney U test: Z = -0.292; P = 0.311 | ||||||||
| < 200/> 400 = Mann-Whitney U test: Z = -2.584; P = 0.010a | ||||||||
| 200-400/> 400 = Mann-Whitney U test: Z = -0.820; P = 0.446 | ||||||||
| Vitamin D (ng/mL) | ||||||||
| ≤ 20 | 22 | 279.8 ± 108.9 | 150.0 | 513.0 | 199.7 | 241.0 | 344.0 | Mann-Whitney U test: Z = -1.6916; P = 0.0907 |
| > 20 | 23 | 372.0 ± 179.8 | 161.0 | 850.0 | 214.0 | 385.0 | 458.9 | |
| PLT (109/ L) | ||||||||
| ≤ 100 | 40 | 350.8 ± 171.4 | 161 | 850 | 207.2 | 312.7 | 412.1 | Mann-Whitney U test: Z = -0.02898; P = 0.9769 |
| > 100 | 31 | 340.2 ± 136.0 | 150 | 598 | 239.0 | 337.0 | 405.0 | |
| D-dimer (µg/mL) | ||||||||
| ≤ 500 | 6 | 205.2 ± 38.5 | 150 | 262 | 187.2 | 203.5 | 225.0 | Mann-Whitney U test: Z = 2.6407; P = 0.0083a |
| > 500 | 63 | 355.9 ± 156.2 | 150 | 850 | 216.0 | 337.0 | 411.5 | |
- Citation: Curakova Ristovska E, Genadieva-Dimitrova M. Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators. World J Hepatol 2022; 14(4): 812-826
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/812.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.812